Boyang Wang on Targeting Underfunded Longevity Projects SINGAPORE, SG / ACCESS Newswire / July 16, 2025 / Immortal Dragons, a ...

Propel Health, a leading provider of strategic communications and engagement services to the life sciences industry, today ...

It is trying to treat a devastating lifelong disease by fixing it at its source. We are able to fix the actual genetic ...

While Novartis holds a diversified product portfolio, there is some product concentration with its largest drugs, Entresto (close to 15% of sales) and Cosentyx (close to 10% of sales). Both drugs will ...

IN 1971 RICHARD NIXON, then America’s president, announced a “war on cancer". Just two years earlier the Apollo programme had ...

The process allows the children to get most of their DNA from their parents, while also avoiding mitochondrial diseases their mother might otherwise have passed on.

The 2025 CSAR Student Award winners were presented with their certificates by Dr Diarmuid O’Brien, the University of ...

ERA Congress 2025 marked a pivotal moment in nephrology this year, bringing together over 9,000 global experts to explore ...

Caribou Biosciences' allogeneic CAR T-cell therapies show promising early efficacy and safety, but require clinical ...

Scott Rubner, Citadel Securities' new head of equity and equity derivatives strategy, expects "robust" retail trading flows ...

These companies have compelling long-term futures, but the coming decade could prove particularly exciting as each one comes into its own.

Chemotherapy used to target and kill bladder cancer cells may trigger an inflammatory response that ultimately may make the ...